Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Aug-24 4:22 PM View:  | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 930 | $12.24 | $11,383.20 | < 1% 117.12K to 118.05K | |
| 06-Aug-24 4:21 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 1,055 | $12.24 | $12,913.20 | < 1% 251.24K to 252.29K | |
| 06-Aug-24 4:19 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 1,286 | $12.24 | $15,740.60 | < 1% 219.18K to 220.47K | |
| 06-Aug-24 4:16 PM View: | Puri Michal Nath Chief Human Resources Officer | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 1,736 | $12.24 | $21,248.60 | 2% 109.17K to 110.9K | |
| 06-Aug-24 4:17 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 1,736 | $12.24 | $21,248.60 | 1% 160.1K to 161.83K | |
| 06-Aug-24 4:19 PM View: | Danziger Asaf Chief Executive Officer Director | Novocure Ltd (NVCR) | 28-Jun-24 | Grant | 1,239 | $12.24 | $15,165.40 | 9% 13.99K to 15.23K | |
| 06-Jun-24 6:37 PM View: | Ocean Allyson J Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 100% 0 to 4.05K | |
| 06-Jun-24 5:43 PM View: | Stafford Kristin Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 100% 0 to 4.05K | |
| 06-Jun-24 6:13 PM View: | Madden Martin J. Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 26% 15.62K to 19.67K | |
| 06-Jun-24 5:43 PM View: | Vernon W Anthony Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 1% 330.63K to 334.68K | |
| 07-Jun-24 4:06 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 05-Jun-24 | Option Exercise | 124,373 | $22.82 | $2,838,190.00 | 50% 251.24K to 375.61K | |
| 06-Jun-24 5:09 PM View: | Hilleman Jeryl L Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 160% 2.54K to 6.59K | |
| 06-Jun-24 5:55 PM View: | Hung David Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 44% 9.14K to 13.19K | |
| 06-Jun-24 5:42 PM View: | Leung Gabriel Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 3% 157.31K to 161.37K | |
| 06-Jun-24 5:42 PM View: | Scannell Timothy J Director | Novocure Ltd (NVCR) | 05-Jun-24 | Grant | 4,053 | -- | -- | 59% 6.89K to 10.95K | |
| 06-Jun-24 5:42 PM View: | Leung Gabriel Director | Novocure Ltd (NVCR) | 04-Jun-24 | Sale | 964 | $23.89 | $23,025.20 | (< 1%) 158.28K to 157.31K | |
| 06-Jun-24 5:42 PM View: | Scannell Timothy J Director | Novocure Ltd (NVCR) | 04-Jun-24 | Sale | 964 | $23.89 | $23,027.50 | (12%) 7.86K to 6.89K | |
| 06-Jun-24 5:43 PM View: | Vernon W Anthony Director | Novocure Ltd (NVCR) | 04-Jun-24 | Sale | 964 | $23.89 | $23,032.90 | (< 1%) 331.59K to 330.63K | |
| 05-Mar-24 4:08 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 04-Mar-24 | Sale | 840 | $16.01 | $13,448.40 | (< 1%) 160.94K to 160.1K | |
| 05-Mar-24 4:09 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 04-Mar-24 | Sale | 1,217 | $16.01 | $19,484.20 | (< 1%) 252.45K to 251.24K | |
| 05-Mar-24 4:09 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 01-Mar-24 | Sale | 2,107 | $16.03 | $33,768.70 | (< 1%) 254.56K to 252.45K | |
| 05-Mar-24 4:08 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 01-Mar-24 | Sale | 1,679 | $16.03 | $26,909.20 | (1%) 162.62K to 160.94K | |
| 29-Feb-24 4:38 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 28-Feb-24 | Sale | 2,078 | $16.14 | $33,544.70 | (1%) 164.69K to 162.62K | |
| 29-Feb-24 4:35 PM View: | Weinberg Uri Chief Innovation Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 81,799 | $16.30 | $1,333,320.00 | 92% 89.35K to 171.15K | |
| 29-Feb-24 10:00 PM View: | Puri Michal Nath Chief Human Resources Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 71,574 | $16.30 | $1,166,660.00 | 190% 37.59K to 109.17K | |
| 29-Feb-24 4:38 PM View: | Leonard Frank X EVP, Pres., Novocure Oncology | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 102,249 | $16.30 | $1,666,660.00 | 164% 62.45K to 164.69K | |
| 29-Feb-24 4:33 PM View: | Giladi Moshe Chief Science Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 51,124 | $16.30 | $833,321.00 | 274% 18.65K to 69.77K | |
| 29-Feb-24 4:30 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 81,799 | $16.30 | $1,333,320.00 | 232% 35.32K to 117.12K | |
| 29-Feb-24 10:00 PM View: | Leupin Nicolas Chief Medical Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 51,124 | $16.30 | $833,321.00 | 100% 0 to 51.12K | |
| 29-Feb-24 4:43 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 27-Feb-24 | Grant | 102,249 | $16.30 | $1,666,660.00 | 87% 117.62K to 219.87K | |
| 29-Feb-24 4:30 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 31-Dec-23 | Grant | 128 | $12.69 | $1,624.32 | < 1% 35.2K to 35.32K | |
| 08-Nov-23 4:22 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 07-Nov-23 | Sale (Planned) | 382 | $12.65 | $4,832.30 | (< 1%) 124.89K to 124.51K | |
| 02-Nov-23 4:20 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 02-Nov-23 | Option Exercise | 175 | $11.46 | $2,005.50 | < 1% 117.44K to 117.62K | |
| 02-Nov-23 4:20 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 31-Oct-23 | Option Exercise | 17,793 | $9.58 | $170,447.00 | 18% 99.65K to 117.44K | |
| 03-Nov-23 4:08 PM View: | Puri Michal Nath Chief Human Resources Officer | Novocure Ltd (NVCR) | 31-Oct-23 | Grant | 37,593 | -- | -- | 100% 0 to 37.59K | |
| 05-Sep-23 4:24 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 294 | $21.82 | $6,414.26 | (< 1%) 210.12K to 209.82K | |
| 05-Sep-23 4:23 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 273 | $21.82 | $5,956.10 | (< 1%) 125.17K to 124.89K | |
| 05-Sep-23 4:24 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 01-Sep-23 | Sale | 883 | $21.82 | $19,264.60 | (< 1%) 100.53K to 99.65K | |
| 04-Aug-23 4:02 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 02-Aug-23 | Sale | 1,144 | $30.25 | $34,607.30 | (1%) 101.68K to 100.53K | |
| 06-Jul-23 4:14 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | < 1% 124.8K to 125.17K | |
| 06-Jul-23 4:13 PM View: | Ben Arye Barak General Counsel | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 288 | $35.28 | $10,160.60 | < 1% 34.91K to 35.2K | |
| 06-Jul-23 4:14 PM View: | Burke William Patrick Chief Human Resources Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 357 | $35.28 | $12,595.00 | < 1% 66.09K to 66.45K | |
| 06-Jul-23 4:12 PM View: | Danziger Asaf Chief Executive Officer Director | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | 3% 13.62K to 13.99K | |
| 06-Jul-23 4:14 PM View: | Groenhuysen Wilhelmus Cm Chief Operating Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 366 | $35.28 | $12,912.50 | < 1% 209.75K to 210.12K | |
| 06-Jul-23 4:13 PM View: | Cordova Ashley Chief Financial Officer | Novocure Ltd (NVCR) | 30-Jun-23 | Grant | 367 | $35.28 | $12,947.80 | < 1% 101.31K to 101.68K | |
| 09-Jun-23 4:05 PM View: | Vernon W Anthony Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 2% 161.94K to 165.8K | |
| 09-Jun-23 4:04 PM View: | Leung Gabriel Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 5% 75.29K to 79.14K | |
| 09-Jun-23 4:05 PM View: | Scannell Timothy J Director | Novocure Ltd (NVCR) | 07-Jun-23 | Grant | 3,853 | -- | -- | 5137% 75 to 3.93K | |
| 07-Mar-23 4:52 PM View: | Leonard Frank X President, CNS Cancers US | Novocure Ltd (NVCR) | 07-Mar-23 | Sale | 8,318 | $75.16 | $625,205.00 | (13%) 62.6K to 54.28K | |
| 07-Mar-23 4:52 PM View: | Shah Pritesh Chief Growth Officer | Novocure Ltd (NVCR) | 03-Mar-23 | Private Sale | 21,421 | $76.16 | $1,631,410.00 | (15%) 146.22K to 124.8K |
